Fibroblast growth factor 21 (FGF21) is increased in MDD and interacts with body mass index (BMI) to affect depression trajectory

Fibroblast growth factor 21 (FGF21) is a key regulator of metabolic function and nutrient preference. It also affects biological pathways associated with major depressive disorder (MDD), including corticotrophin-releasing hormone (CRH), leptin, and sympathetic activity. Lower levels of cerebrospinal...

Descripción completa

Detalles Bibliográficos
Autores principales: Mason, Brittany L., Minhajuddin, Abu, Czysz, Andrew H., Jha, Manish K., Gadad, Bharathi S., Mayes, Taryn L., Trivedi, Madhukar H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752780/
https://www.ncbi.nlm.nih.gov/pubmed/35017468
http://dx.doi.org/10.1038/s41398-021-01679-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752780/
https://www.ncbi.nlm.nih.gov/pubmed/35017468
http://dx.doi.org/10.1038/s41398-021-01679-y

Ejemplares similares